CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting Oct 18, 2021 7:00am EDT
Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid Oct 14, 2021 7:00am EDT
CytoDyn to Present at Emerging Growth Conference on October 13 Followed by Live Q/A Oct 07, 2021 2:27pm EDT
CytoDyn Announces Study to Evaluate Potential Synergistic Effects of Leronlimab with Immune Checkpoint Blockade (ICB) Oct 07, 2021 6:02am EDT
CytoDyn Names Chris Recknor, M.D. Senior Executive VP of Clinical Operations to Initiate Two New Clinical Trials for Stroke and Alzheimer’s, While Nitya Ray, Ph.D. is Named CytoDyn’s New COO to Lead CMC and Regulatory Operations Specifically the BLA for HIV Oct 07, 2021 6:01am EDT
CytoDyn Announces Legal Actions Against its Former CRO, Amarex Clinical Research Oct 07, 2021 6:00am EDT
CytoDyn to Present at Emerging Growth Conference on September 29 Followed by Live Q/A Sep 27, 2021 12:30pm EDT
CytoDyn Receives Clearance from Brazil’s FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week) Sep 22, 2021 8:00am EDT
CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021 Sep 21, 2021 8:00am EDT
